-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathDESCRIPTION
40 lines (40 loc) · 1.51 KB
/
DESCRIPTION
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Type: Package
Package: GSVAutils
Title: GSVA and Related Functions for Tumor Immunogenicity Score
Project
Version: 0.1.0
Author: Shixiang Wang
Maintainer: Shixiang Wang <w_shixiang@163.com>
Description: Immunotherapy, represented by immune checkpoint
inhibitors (ICI), is transforming the treatment of cancer. However,
only a small percentage of patients show response to ICI, and there is
an unmet need for biomarkers that will identify patients who are more
likely to respond to immunotherapy. The fundamental basis for ICI
response is the immunogenicity of a tumor, which is primarily
determined by tumor antigenicity and antigen presentation efficiency.
Here, we propose a method to measure tumor immunogenicity score
(TIGS), which combines tumor mutational burden (TMB) and an expression
signature of the antigen processing and presenting machinery (APM).
In both correlation with pan-cancer ICI objective response rates (ORR)
and ICI clinical response prediction for individual patients, TIGS
consistently showed improved performance compared to TMB and other
known prediction biomarkers for ICI response. This study suggests that
TIGS is an effective tumor-inherent biomarker for ICI-response
prediction.
License: Apache License (>= 2.0)
Depends:
R (>= 3.5.0)
Imports:
Biobase,
dplyr,
GSVA,
magrittr,
rlang (>= 0.1.2),
tibble
Suggests:
roxygen2
biocViews:
Encoding: UTF-8
LazyData: true
Roxygen: list(markdown = TRUE)
RoxygenNote: 7.0.0